FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Centerline Biomedical Raises $33 Million in Series B Financing
Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.
MicroTransponder Raises $53M
MicroTransponder plans to use the funds to commercialize the Vivistim® Paired VNS™ System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.
Artio Medical Closes $28M in Additional Series A Financing
Artio Medical notes the funds will be used to support US commercialization efforts for the recently cleared Solus Gold™ Embolization Device and to accelerate the development of Artio's broad portfolio of products.
Lauxera Capital Partners Invests €10m In Matrix Requirements
Founded in 2014, Matrix Requirements supports the R&D, Regulatory Affairs and Quality departments of MedTech companies by providing specialized digital tools for medical device design, traceability, quality management and regulatory compliance.
Able Innovations Works to Transform Frontline Healthcare with USD $6MM in Funding
Able Innovations is using robotics to transform processes for healthcare staff by incorporating safety and dignity into a routine procedure that affects providers and patients.
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
PathMaker Neurosystems notes this Stage I START funding was awarded on the basis of PathMaker’s $4.9M grant from the NINDS Cooperative Research to Enable and Advance Translational Enterprises for Devices (CREATE Devices) program to develop MyoRegulator®, a first-in-class, non-invasive neuromodulation device for treating muscle spasticity.
QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics
The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol “QDEL.”
Synergy Health Network’s $100 Mil Expansion Starts with Crowdfunding via Rialto Markets
Synergy Health Network is giving investors the chance to back its expansion plans after teaming up with Rialto Markets to utilise the award-winning broker-dealer’s crowdfunding platform and infrastructure for a $1 million Reg CF raise to launch Synergy’s four-year growth mission.
Deciphex Raises $11.5M in Series B Funding Led by ACT Venture Capital
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Medical Device News Magazine